CS21192A3 - Complex containing precipitation factor ix - Google Patents

Complex containing precipitation factor ix

Info

Publication number
CS21192A3
CS21192A3 CS92211A CS21192A CS21192A3 CS 21192 A3 CS21192 A3 CS 21192A3 CS 92211 A CS92211 A CS 92211A CS 21192 A CS21192 A CS 21192A CS 21192 A3 CS21192 A3 CS 21192A3
Authority
CS
Czechoslovakia
Prior art keywords
factor
complex containing
containing precipitation
precipitation factor
vitamin
Prior art date
Application number
CS92211A
Other languages
English (en)
Inventor
Yendra Dr Linnau
Maria Dipl Ing Sazgary
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of CS21192A3 publication Critical patent/CS21192A3/cs
Publication of CZ280297B6 publication Critical patent/CZ280297B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
CS92211A 1991-01-25 1992-01-24 Komplex obsahující srážecí faktor IX CZ280297B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016391A AT402261B (de) 1991-01-25 1991-01-25 Komplex enthaltend den gerinnungsfaktor ix

Publications (2)

Publication Number Publication Date
CS21192A3 true CS21192A3 (en) 1992-08-12
CZ280297B6 CZ280297B6 (cs) 1995-12-13

Family

ID=3483232

Country Status (12)

Country Link
US (2) US5281661A (cs)
EP (1) EP0496725B1 (cs)
JP (2) JP2651307B2 (cs)
AT (2) AT402261B (cs)
CA (1) CA2059979C (cs)
CZ (2) CZ280725B6 (cs)
DE (1) DE59207638D1 (cs)
DK (1) DK0496725T3 (cs)
ES (1) ES2098485T3 (cs)
FI (1) FI100111B (cs)
HU (1) HU212362B (cs)
SK (2) SK280989B6 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015324A1 (en) 1991-03-01 1992-09-17 Rhone-Poulenc Rorer International (Holdings) Inc. Preparation of factor ix
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
US5888826A (en) * 1994-06-30 1999-03-30 Dade Behring Inc. Combination reagent holding and test device
US5602037A (en) * 1994-06-30 1997-02-11 Dade International, Inc. Combination reagent holding and test device
WO1996000899A1 (en) * 1994-06-30 1996-01-11 Dade International Inc. Bioactive porous partition members
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
CN1284881A (zh) * 1997-11-05 2001-02-21 吉富制药株式会社 肝素辅助因子ⅱ制剂及其制备方法
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR101100059B1 (ko) * 2004-06-30 2011-12-29 넥타르 테라퓨틱스 중합체­인자 ｉｘ 부분의 접합체
EP2360171A1 (en) 2004-12-23 2011-08-24 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
EP2477603B1 (en) 2009-09-17 2016-03-30 Baxalta Incorporated Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
TWI621625B (zh) 2010-09-17 2018-04-21 巴克斯歐塔公司 在弱酸性至中性ｐｈ中經由具有組胺酸的水性調配物穩定免疫球蛋白
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
WO2012154272A1 (en) 2011-02-25 2012-11-15 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
DE3751605D1 (de) * 1986-01-06 1996-01-04 Blood Systems Inc Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung.
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3914869C1 (cs) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
HU9200225D0 (en) 1992-04-28
ATE146220T1 (de) 1996-12-15
US5281661A (en) 1994-01-25
EP0496725A2 (de) 1992-07-29
FI920342A0 (fi) 1992-01-24
CA2059979A1 (en) 1992-07-26
CZ154794A3 (en) 1996-04-17
JP2651307B2 (ja) 1997-09-10
US5409990A (en) 1995-04-25
HU212362B (en) 1996-06-28
AT402261B (de) 1997-03-25
ATA16391A (de) 1996-08-15
JPH08259449A (ja) 1996-10-08
SK280989B6 (sk) 2000-10-09
DE59207638D1 (de) 1997-01-23
JP2866047B2 (ja) 1999-03-08
SK280130B6 (sk) 1999-08-06
JPH04295432A (ja) 1992-10-20
EP0496725B1 (de) 1996-12-11
EP0496725A3 (en) 1993-05-05
FI100111B (fi) 1997-09-30
DK0496725T3 (da) 1997-06-09
ES2098485T3 (es) 1997-05-01
FI920342L (fi) 1992-07-26
CA2059979C (en) 2003-04-15
CZ280725B6 (cs) 1996-04-17
HUT63863A (en) 1993-10-28
CZ280297B6 (cs) 1995-12-13

Similar Documents

Publication Publication Date Title
CS21192A3 (en) Complex containing precipitation factor ix
NZ332625A (en) Concentrated antibody preparation containing greater than 100 mg/ml of the antibody
IL122460A0 (en) Preparation of an acylated protein powder
SE8206168D0 (sv) Preparations and process for preparation thereof
NZ310710A (en) Fermentative production of hydrophobic proteins such as ifn-<beta>
FI931274A0 (fi) Menetelmä puhdistettujen glykolipidien valmistamiseksi käyttäen membraanierotusmenetelmää
CA2178208A1 (en) Purification of vitamin-k dependent proteins by membrane chromatography
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
TNSN86154A1 (fr) Procede pour la preparation de cefodizime
MY103874A (en) Process for the preparation of 5-chloro-3-chlorosulpho- nyl-2-thiophenecarboxylic acid esters.
EP0776969A3 (de) Verfahren zur Herstellung von Proteinen durch kontrollierte proteolytische spaltung von Pro-Proteinen
HU913573D0 (en) Complexes containing s(+)alkaneacids and alpha-hydroxy-alkaneacids
EP0135135A3 (en) Method and apparatus for trace gas detection
AU3579589A (en) Process for producing concentrates from aqueous liquids
AU625831B2 (en) Solubilization of t-pa
JPS5251089A (en) Method of immobilizing glutathione-synthetase and process of producing glutathione with the immobilized synthetase
JPS6488366A (en) Iron colloid labeling antibody and preparation thereof and histocytochemical detection
JPS55100321A (en) Production of glycoprotein
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
JPS5261289A (en) Separation of urokinase
UA9369A1 (uk) Засіб збагачуваhhя слабомагhітhих руд

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20020124